Medical Necessity of Defencath for Hemodialysis Patients with CVC

Background and Clinical Context

The American Thoracic Society recommends Defencath (taurolidine) 81 mg IVP three times weekly for 3 months for certain patients, however the context is unclear 1

The Infectious Diseases Society of America recommends antibiotic ointment or heparin as medically necessary supplies for infection prevention in hemodialysis patients with central venous catheters 2, 3
For patients requiring prophylactic antibiotics before invasive procedures, the recommended agents are amoxicillin (2g orally 1 hour before procedure) or clindamycin (600mg orally 1 hour before procedure) for penicillin-allergic patients, as suggested by the American Dental Association 4
There are no established guidelines supporting the routine use of intravenous taurolidine (Defencath) as prophylaxis for catheter-related infections in hemodialysis patients, according to the Infectious Diseases Society of America 2, 3

The National Kidney Foundation recommends careful consideration of renal clearance and potential toxicity when dosing medications in ESRD patients 3, 5
For patients on hemodialysis, antimicrobial dosing typically requires adjustment with reduced frequency (e.g., 2-3 times weekly rather than daily) but maintaining adequate dose per administration to achieve therapeutic effect, as recommended by the American Thoracic Society 6, 7
When antibiotics are indicated for hemodialysis patients, they should be administered after dialysis to prevent premature removal of the drug, according to the American Thoracic Society 6, 1

Defencath (taurolidine) 81 mg IVP 3 times weekly is not considered medically necessary for hemodialysis patients based on current guidelines and standard of care, as stated by the Infectious Diseases Society of America 2, 3
Standard catheter care with antibiotic ointment at the insertion site and proper heparin locking would be the appropriate approach for infection prevention, as recommended by the Infectious Diseases Society of America 2, 3

Unnecessary antimicrobial use increases risk of resistance development and potential adverse effects, according to the Infectious Diseases Society of America 3, 5
Medication costs and burden should be considered, especially when not supported by evidence-based guidelines, as suggested by the Infectious Diseases Society of America 3
If the patient has had recurrent catheter-related infections, the approach to prophylaxis might need reconsideration with input from infectious disease specialists, as recommended by the American Dental Association 4